Overcoming therapeutic inertia with inhaled insulin

In this episode, we examine the concept of "therapeutic inertia" in diabetes care. Dr. David Ahn is joined by Dr. Grazia Aleppo, Professor of Medicine at the Feinberg School of Medicine, Northwestern University, to explore how inhaled insulin can help address the clinical and behavioral barriers often associated with insulin initiation.Key discussion points:Defining therapeutic inertia in the context of insulin initiation.Common clinician and patient-related barriers that contribute to treatment delays.Practical strategies for introducing inhaled insulin to hesitant patients.System-level considerations, including workflow and reimbursement challenges.Find more resources and exclusive content on the ATTD Education Portal: https://unlok-education.com/attd/Make sure to subscribe to the ATTD Diabetes Talks podcast for more insights and updates. Let’s advance diabetes care together.#DiabetesCare #Endocrinology #InhaledInsulin #ATTD #MedicalPodcastChapters:00:00 Why Inhaled Insulin Matters00:34 Show Intro and Guest01:22 Defining Therapeutic Inertia02:19 Clinician Barriers to Insulin03:49 Patient Fears and Hesitation05:28 How Inhaled Insulin Helps07:00 Best Fit Patient Scenarios08:22 Talking to Hesitant Patients10:39 Workflow and Coverage Hurdles13:35 PFT Testing and Side Effects14:47 Future Role and Wrap Up